title: The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype?
abstract: BACKGROUND
  Hemochromatosis is a recessively inherited disorder caused by a point mutation, C282Y of the HFE gene on chromosome 6p21.3 near the human leukocyte antigen (HLA) locus. It is unknown why some homozygotes develop a severe iron loading, while others do not. A recent study suggested that the A1-B8 haplotype may be associated with higher iron storage.
  
  
  METHODS
  We studied HLA haplotypes of 85 probands, 31 females and 54 males, and their family members from a rural population where A1-B8 was common. We tested the hypothesis of a modifying effect of the A1-B8 haplotype.
  
  
  RESULTS
  Most homozygotes had a mild phenotypic expression, and were often detected accidentally because of a laboratory routine including transferrin saturation. A disease-related morbidity [serum alanine aminotransferase (S-ALT) > 43 U] was present in 40%. Three had porphyria cutanea tarda. Two brothers with A1-B8 died of bronze diabetes, probably caused by co-inheritance of congenital spherocytosis. In females there were no significant differences in phenotypic expression between groups with regard to the presence or absence of A1-B8. Two females, <50 yr of age, with this haplotype had iron deficiency. Males with two copies of A1-B8 had significantly lower serum ferritin (P = 0.02) values than those without. Those with one A1-B8 haplotype were not different from those without. In men without A1-B8, those carrying HLA-A3 were not phenotypically different from those without this ancestral haplotype.
  
  
  CONCLUSIONS
  The A1-B8 haplotype hitchhiking with the C282Y mutation was not associated with a more efficient iron absorption. On the contrary, males with double copies of this haplotype expressed a milder phenotype, possibly an effect of local (environmental and/or genetic) factors.
authors.affiliation: Department of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden. sigvard.olsson@medic.gu.se
authors.forename: K Sigvard
authors.initials: KS
authors.lastname: Olsson
authors.forename: Bernd
authors.initials: B
authors.lastname: Ritter
authors.forename: Norbeth
authors.initials: N
authors.lastname: Hansson
mesh_terms: D000328:Adult; D000368:Aged; D003545:Cysteine; D005260:Female; D005293:Ferritins / Q000097:blood; D015788:HLA-A1 Antigen / Q000235:genetics*; D015791:HLA-A3 Antigen / Q000235:genetics; D015795:HLA-B8 Antigen / Q000235:genetics*; D006239:Haplotypes; D006432:Hemochromatosis / Q000235:genetics*; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006801:Humans; D000090463:Iron Deficiencies; D008297:Male; D008565:Membrane Proteins / Q000235:genetics; D008875:Middle Aged; D009154:Mutation; D010375:Pedigree; D010641:Phenotype; D013548:Sweden; D014443:Tyrosine
chemical_list: C103673:HFE protein, human; D015788:HLA-A1 Antigen; D015791:HLA-A3 Antigen; D015795:HLA-B8 Antigen; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins; D014443:Tyrosine; D005293:Ferritins; D003545:Cysteine